475 related articles for article (PubMed ID: 22751495)
21. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.
Freeman AF; Holland SM
Pediatr Res; 2009 May; 65(5 Pt 2):32R-37R. PubMed ID: 19190525
[TBL] [Abstract][Full Text] [Related]
22. Severe eczema and Hyper-IgE in Loeys-Dietz-syndrome - contribution to new findings of immune dysregulation in connective tissue disorders.
Felgentreff K; Siepe M; Kotthoff S; von Kodolitsch Y; Schachtrup K; Notarangelo LD; Walter JE; Ehl S
Clin Immunol; 2014 Jan; 150(1):43-50. PubMed ID: 24333532
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the Role of
Moffitt K; Cheung E; Manis J; Malley R
Infect Immun; 2018 May; 86(5):. PubMed ID: 29463618
[TBL] [Abstract][Full Text] [Related]
24. Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.
Kumánovics A; Perkins SL; Gilbert H; Cessna MH; Augustine NH; Hill HR
J Clin Immunol; 2010 Nov; 30(6):886-93. PubMed ID: 20859667
[TBL] [Abstract][Full Text] [Related]
25. A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis.
Kasap N; Celik V; Isik S; Cennetoglu P; Kiykim A; Eltan SB; Nain E; Ogulur I; Baser D; Akkelle E; Celiksoy MH; Kocamis B; Cipe FE; Yucelten AD; Karakoc-Aydiner E; Ozen A; Baris S
Clin Immunol; 2021 Feb; 223():108645. PubMed ID: 33301882
[TBL] [Abstract][Full Text] [Related]
26. Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function.
Ives ML; Ma CS; Palendira U; Chan A; Bustamante J; Boisson-Dupuis S; Arkwright PD; Engelhard D; Averbuch D; Magdorf K; Roesler J; Peake J; Wong M; Adelstein S; Choo S; Smart JM; French MA; Fulcher DA; Cook MC; Picard C; Durandy A; Tsumura M; Kobayashi M; Uzel G; Casanova JL; Tangye SG; Deenick EK
J Allergy Clin Immunol; 2013 Aug; 132(2):400-11.e9. PubMed ID: 23830147
[TBL] [Abstract][Full Text] [Related]
27. Phenotyping and long-term follow up of patients with hyper IgE syndrome.
Alyasin S; Esmaeilzadeh H; Ebrahimi N; Nabavizadeh SH; Kashef S; Esmaeilzadeh E; Babaei M; Amin R
Allergol Immunopathol (Madr); 2019; 47(2):152-158. PubMed ID: 30279075
[TBL] [Abstract][Full Text] [Related]
28. [Hyper-IgE syndrome. Lessons from function and defects of STAT-3 or DOCK-8].
Alcántara-Montiel JC; Vega-Torres BI
Rev Alerg Mex; 2016; 63(4):385-396. PubMed ID: 27795219
[TBL] [Abstract][Full Text] [Related]
29. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in mainland China.
Zhang LY; Tian W; Shu L; Jiang LP; Zhan YZ; Liu W; Zhao XD; Cui YX; Tang XM; Wang M; Wu DQ; Yang XQ
Scand J Immunol; 2013 Sep; 78(3):258-65. PubMed ID: 23659370
[TBL] [Abstract][Full Text] [Related]
30. Clinical manifestations of hyper IgE syndromes.
Freeman AF; Holland SM
Dis Markers; 2010; 29(3-4):123-30. PubMed ID: 21178271
[TBL] [Abstract][Full Text] [Related]
31. Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome.
Patel NC; Gallagher JL; Torgerson TR; Gilman AL
J Clin Immunol; 2015 Jul; 35(5):479-85. PubMed ID: 25962528
[TBL] [Abstract][Full Text] [Related]
32. Clinical aspects and genetic analysis of Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES).
Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Hsieh MY; Huang YC; Kuo HC; Yang KD; Yu HR; Jaing TH; Yang CH
J Clin Immunol; 2011 Apr; 31(2):272-80. PubMed ID: 21120687
[TBL] [Abstract][Full Text] [Related]
33.
Danion F; Aimanianda V; Bayry J; Duréault A; Wong SSW; Bougnoux ME; Tcherakian C; Alyanakian MA; Guegan H; Puel A; Picard C; Lortholary O; Lanternier F; Latgé JP
Front Immunol; 2020; 11():38. PubMed ID: 32047500
[TBL] [Abstract][Full Text] [Related]
34. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.
Milner JD; Brenchley JM; Laurence A; Freeman AF; Hill BJ; Elias KM; Kanno Y; Spalding C; Elloumi HZ; Paulson ML; Davis J; Hsu A; Asher AI; O'Shea J; Holland SM; Paul WE; Douek DC
Nature; 2008 Apr; 452(7188):773-6. PubMed ID: 18337720
[TBL] [Abstract][Full Text] [Related]
35.
Park B; Liu GY
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271763
[TBL] [Abstract][Full Text] [Related]
36. The hyper-IgE syndromes.
Freeman AF; Holland SM
Immunol Allergy Clin North Am; 2008 May; 28(2):277-91, viii. PubMed ID: 18424333
[TBL] [Abstract][Full Text] [Related]
37. Life-Threatening Pneumopathy and
Deverrière G; Lemée L; Grangé S; Boyer S; Picard C; Fischer A; Marguet C
Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562253
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis of hyper IgE syndrome.
Heimall J; Freeman A; Holland SM
Clin Rev Allergy Immunol; 2010 Feb; 38(1):32-8. PubMed ID: 19452285
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary Infections and Surgical Complications in a Young Girl with Signal Transducer and Activator of Transcription 3 Loss-of-Function Mutation Hyperimmunoglobulin E Syndrome: A Case Report.
Toribio-Dionicio C; Cubas-Guzmán D; Guerra-Canchari P; García-Sánchez V; Córdova-Calderón W
Pediatr Allergy Immunol Pulmonol; 2021 Mar; 34(1):33-37. PubMed ID: 33734873
[No Abstract] [Full Text] [Related]
40. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
